Ramos-Álvarez, Irene <br/><br/>
Bombesin receptor subtype-3 (BRS-3), a novel candidate as therapeutic molecular target in obesity and diabetes.  [electronic resource] 

 -  Molecular and cellular endocrinology  Mar 2013 
 - 109-15 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-8057 
<br/><br/><label>Standard No.: </label>10.1016/j.mce.2012.12.025  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Androstadienes--pharmacology<br/>Animals<br/>Biological Transport--drug effects<br/>Cells, Cultured<br/>Diabetes Mellitus, Type 2--genetics<br/>Female<br/>Flavonoids--pharmacology<br/>Gene Expression Regulation--drug effects<br/>Glucose--metabolism<br/>Glucose Transporter Type 4--genetics<br/>Humans<br/>Insulin--pharmacology<br/>Male<br/>Mice<br/>Mice, Knockout<br/>Middle Aged<br/>Molecular Targeted Therapy<br/>Muscle Cells--drug effects<br/>Muscle, Skeletal--metabolism<br/>Obesity--genetics<br/>Peptides--pharmacology<br/>Receptors, Bombesin--agonists<br/>Sirolimus--pharmacology<br/>Wortmannin